Skip to Main Content

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. 

What to know about insurtech earnings


Oscar Health and Clover Health have generated a ton of hype with their promises to make health insurance more efficient with tech, but they’re still proving the financial merits of their models, analysts say. Both have seen dismal stock performances since their closely watched entrances into the public market, and they’re still grasping for profits despite increasing membership and revenues. In a new story, Cowen’s Gary Taylor tells Mohana that their stock performance belies investor skepticism, and that it’s not yet clear that sophisticated software can actually cut medical loss ratios or help turn profits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.